The STARS-BNP trial [42] was the first large trial to demonstrate improved outcomes using a natriuretic peptide-guided approach in patients with HF. The investigators enrolled 220 participants ...

There are many hemodynamic effects of BNP which are beneficial in the setting of decompensated congestive heart failure including arterial and venous vasodilation and increased excretion of sodium ...

B-type natriuretic peptide (BNP) and the N-terminal fragment of its prohormone (NT-proBNP) are powerful markers of adverse outcome, and in particular of the development of heart failure and death.

In the study data from more than 800 people at different stages of heart failure was used and people were measured for levels of the hormone B-Type Natriuretic Peptide (BNP), a hormone currently ...

BNP is a “stretch” hormone that indicates stretching or increased pressure that occurs with HF. Based on the stage of your heart failure, a doctor will work with you to create a treatment plan ...

B-type natriuretic peptide, and another chemical derived from it (collectively referred to as BNP), are hormones secreted by the heart in response to injury and their levels in the blood are raised in ...

Brain natriuretic peptides (BNPs) are released from cardiac myocytes in times of ventricular wall stress; their levels correlate with the severity of heart failure. The prognostic value of BNP ...

An assay measuring N-terminal pro-BNP, or NT-proBNP, is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...